#United States #Cannabix Technologies #Omega Laboratories #Mogadore #Breath Testing

Innovative Breath Testing Method Validated

In a significant development for drug testing technology, Omega Laboratories and Cannabix Technologies announced the publication of a peer-reviewed study in the Journal of Analytical Toxicology. This study showcases an innovative method for detecting cannabinoids in breath samples, specifically targeting recent marijuana use. The complete title of the publication is "Simultaneous Analysis of Δ9-THC, Δ8-THC, CBD, and CBN in Breath Aerosols Collected Using Cannabix Technologies Breath Collection Unit.” This marked a notable milestone for breath-based testing in the realm of cannabis detection.

Significance of the Study

The study emphasizes the accuracy and applicability of Omega Laboratories' methods for detecting marijuana usage through breath samples collected via Cannabix Technologies' Breath Collection Unit and Breath Cartridges. This state-of-the-art testing system offers a reliable, non-invasive alternative for employers and law enforcement to determine recent cannabis consumption, thus addressing a crucial gap in traditional drug testing methods which often assess long-term rather than immediate substance use.

The collaboration between Omega and Cannabix, which began with a strategic partnership in May 2024, led to considerable improvements to the design and methodology of the Cannabix Breath Collection Unit (BCU). Over approximately twenty months, the joint teams optimized the BCU for enhanced performance.

Impacts on Drug Testing Protocols

As marijuana usage continues to gain popularity for both recreational and medicinal purposes, the need for effective detection methods in workplace environments, treatment facilities, and public safety initiatives has never been more pressing. The breath testing method proposed in the study provides a timely alternative to the more invasive blood or urine tests, enabling authorities to measure recent cannabis use more accurately. Recent findings indicate that breath samples correlate with recent substance use, offering insights into consumption within a window of up to four hours before collection.

Unlike conventional breathalyzers primarily designed for alcohol detection, marijuana testing is inherently more complex due to the low concentrations of THC in breath. However, Omega Laboratories has honed their techniques over the years to achieve precise results even at these low levels. For decades, they have specialized in using hair, oral fluid, urine, and breath for drug testing.

Key Findings from the Research

The validation study revealed several key advancements:

• - Multi-cannabinoid Detection: The method successfully quantifies various cannabinoids from breath aerosols, including Δ9-THC, Δ8-THC, CBD, and CBN.
• - Enhanced Sensitivity and Simplicity: The laboratory methods are not only quicker but also simpler compared to previous approaches while significantly improving detection sensitivity.
• - Sample Stability: Breath samples collected using the Cannabix Breath Collection Kit can remain stable for up to seven days.
• - Correlation with Blood Metabolism: The study further confirms that the metabolic rate of THC observed in breath aligns with previous data recorded in blood.

Because the analytical process involves complex techniques such as LC-MS/MS, the samples must be analyzed in a laboratory. This means that collections can be conducted on-site at roadblocks, workplaces, or clinics, but analyses will not yield results until the samples reach the laboratory.

A Step Forward for Public Safety

"This publication strengthens the case for utilizing breath as a reliable metric for recent drug usage detection," stated Bill Corl, CEO of Omega Laboratories. The rise in interest around breath testing reflects a broader shift away from traditional methods, responding to the evolving landscape of drug use and drug enforcement. This is further evidenced by the ongoing work of Cannabix in enhancing their BCU manufacturing capabilities.

Rav Mlait, CEO of Cannabix Technologies, expressed his pride in the publication's achievement, acknowledging the collective dedication of their teams. The enhancements made to the Cannabix BCU present various advantages as a consistent and portable tool for cannabis detection in breath.

The advancement of this technology illustrates a promising horizon for ensuring public safety and supporting organizations that strive for informed drug testing protocols. As the demand for accurate, efficient drug testing methods grows, the collaboration between Omega Laboratories and Cannabix Technologies highlights the need for innovation in this vital sector.